Results 211 to 220 of about 97,239 (277)
Blastomycosis, Histoplasmosis, and Coccidioidomycosis in Outpatient Community-Acquired Pneumonia. [PDF]
Benedict K +5 more
europepmc +1 more source
ABSTRACT Context While there is a growing body of evidence on end‐of‐life (EOL) care preferences such as place of death, research remains limited in key areas. This includes gaps in understanding preferred and actual places of EOL care and death (dying places), potential shifts of preferences over time, and their (non‐)alignment with reality.
Sifra Hannah van de Beek +11 more
wiley +1 more source
CURB-65 for community-acquired pneumonia severity using severity index. [PDF]
Tagore PK +5 more
europepmc +1 more source
A Concept Analysis of Expertise Associated With Practicing Clinical Nurses in Hospital Settings
ABSTRACT Aim Analyse the concept of expertise among practicing clinical nurses in hospital settings. Background The generational loss of expert clinical nurses was exacerbated globally by the novel coronavirus. This ongoing loss combined with the increased complexity of hospitalised patients has prompted an urgent need to understand expertise among ...
Jonathan D. Hecht +4 more
wiley +1 more source
Combined nasopharyngeal and oropharyngeal sampling improves pathogen detection in community-acquired pneumonia. [PDF]
Hansen K +5 more
europepmc +1 more source
Hospital at Home in 10 years—Here, borrow my binoculars
Abstract Hospital in the Home (HAH) refers to the delivery of acute hospital care to patients at home, or in their usual place of care, including nursing homes. HAH is an acute hospital substitution service—it delivers medical, nursing and allied health staff, skills, interventions and treatments, technologies and supervision usually found in hospitals
Michael Montalto
wiley +1 more source
Vitamin C Supplementation in Hospitalized Patients With Community-Acquired Pneumonia: Protocol for a Randomized Controlled Trial. [PDF]
Sharma Y +7 more
europepmc +1 more source
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik +3 more
wiley +1 more source
The heterogeneous treatment effect of adjuvant therapy with corticosteroids in patients with Community-Acquired Pneumonia: a review. [PDF]
Smit JM +4 more
europepmc +1 more source

